Feedback / Questions
nintedanib inhaled (RSN0402) - Resproly Biopharma
http://clinicaltrials.gov/ct2/show/NCT06482190
Jul 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next